Mitophagy-related gene signature predicts prognosis, immune infiltration and chemotherapy sensitivity in colorectal cancer

Figure 2 Characterization of the three clusters. A: Differences in metastasis-related pathways scored by gene set variation analysis (GSVA) between cluster I and cluster III; B: Differences in pathway activities scored by GSVA between cluster II and cluster III; C: Relative abundance of 22 tumor-infiltrating immune cells in each of the three clusters. The statistical differences between the three clusters as determined through the Kruskal-Wallis H test. ^aP < 0.05; ^bP < 0.01; ^cP < 0.001.